Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Philipp G Hemmati"'
Autor:
Guillaume Normand, Philipp G. Hemmati, Berlinda Verdoodt, Clarissa von Haefen, Jana Wendt, Dilek Güner, Evelyne May, Bernd Dörken, Peter T. Daniel
Publikováno v:
J Biol Chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0824d511bc01d89f0b5a6e8d351bca8f
https://europepmc.org/articles/PMC10124944/
https://europepmc.org/articles/PMC10124944/
Autor:
Sabine Wohlfarth, Georg Maschmeyer, Matthias Kramer, Harun Badakhshi, Dorothea Fischer, Gerald Ripberger, Philipp G Hemmati, Frank Breywisch, Lukas Tometten, Matthias Paland
Publikováno v:
Oncology Research and Treatment
Treatment of cancer patients has become challenging when large parts of hospital services need to be shut down as a consequence of a local COVID-19 outbreak that requires rapid containment measures, in conjunction with the shifting of priorities to v
Autor:
Philipp G. Hemmati
Publikováno v:
CME. 15:9-22
Autor:
Philipp G. Hemmati
Publikováno v:
best practice onkologie. 13:128-136
Autor:
Theis H. Terwey, Philipp G. Hemmati, Peter Martus, Ekkehart Dietz, Lam G. Vuong, Gero Massenkeil, Bernd Dörken, Renate Arnold
Publikováno v:
Haematologica, Vol 95, Iss 5 (2010)
Background Disease stage is the most important prognostic parameter in allogeneic hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia, but other factors such as donor/host histocompatibility and gender combination, recipient age
Externí odkaz:
https://doaj.org/article/7576510aa35a45a6a2c60163af50ee92
Autor:
Daniel Wolff, Philipp Y. Herzberg, Anne Herrmann, Steven Z. Pavletic, Pia Heussner, Friederike Mumm, Christina Höfer, Inken Hilgendorf, Philipp G. Hemmati, Ernst Holler, Hildegard Greinix, Sandra A. Mitchell
Publikováno v:
Bone Marrow Transplantation. 56:2618-2618
Autor:
Ana, Milojkovic, Philipp G, Hemmati, Annika, Müer, Tim, Overkamp, Cindrilla, Chumduri, Reiner U, Jänicke, Bernd, Gillissen, Peter T, Daniel
Publikováno v:
International journal of cancer. 133(11)
The p14(ARF) tumor suppressor triggers cell death or cell cycle arrest upon oncogenic stress. In MCF-7 breast carcinoma cells, expression of the tumor suppressor gene p14(ARF) fails to trigger apoptosis but induces an arrest in the G1 and, to a lesse
Autor:
Philipp G, Hemmati, Theis H, Terwey, Philipp, le Coutre, Lam G, Vuong, Gero, Massenkeil, Bernd, Dörken, Renate, Arnold
Publikováno v:
European journal of haematology. 86(4)
The systematic and standardized pretransplant risk assessment represents an important tool to predict the outcome of patients undergoing allogeneic stem cell transplantation (alloSCT). To investigate the capacity of a modified European group for bloo
BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients
Autor:
Philipp, le Coutre, Petra, Reinke, Ruth, Neuhaus, Ralf, Trappe, Frauke, Ringel, Marc, Lalancette, Philipp G, Hemmati, Bernd, Dörken, Peter T, Daniel
Publikováno v:
European journal of haematology. 84(1)
The constitutively activated tyrosine kinase activity of the p210(bcr-abl) fusion protein, generated by a t(9;22)(q34;q11) chromosomal translocation, is pathogenetically associated with chronic myeloid leukemia (CML). However, mechanisms contributing